Matthew Cockerill

Matthew Cockerill

Matthew Cockerill is a Technical Strategy Consultant for Sciad ensuring the latest technology is used for Sciad's clients

Matthew has previously run Technical teams in science publishing, most recently at BioMed Central owned by Springer where he went onto become CEO. Matthew currently also runs his own consultancy Alectryon and also heads up the European division of the reproducible research software company Riffyn.